Malaysia has signed an agreement that will give it access to affordable dolutegravir-based treatments for HIV positive patients.

The World Health Organization (WHO) recommends using dolutegravir (DTG) to treat all HIV patients, including pregnant mothers, as it is easier to administer and has been proven to be more effective...